Table 6.
Relationship between health resource utilization and incontinence status a
| Variables |
Incontinence status
b
|
||
|---|---|---|---|
|
Continent |
Incontinent |
||
| (n = 78) | (n = 235) | ||
|
Proportion of patients having OAB-related hospitalization experience during the past 12 months‡ |
USA |
1 (5.0%) |
3 (4.6%) |
| Europe |
9 (15.8%) |
31 (18.2%) |
|
| Total |
10 (12.8%) |
34 (14.5%) |
|
|
Proportion of patients that ever had OAB-related surgery‡ |
USA |
2 (9.5%) |
10 (15.9%) |
| Europe |
6 (10.5%) |
11 (6.5%) |
|
| Total |
8 (10.3%) |
21 (9.1%) |
|
|
Proportion of patients that had switched anticholinergics used for OAB due to efficacy/side effects‡ |
USA |
6 (28.6%) |
15 (23.1%) |
| Europe |
18 (31.6%) |
46 (27.1%) |
|
| Total |
24 (30.8%) |
61 (26.0%) |
|
|
Proportion of patients currently using pads (at the time of completing the survey) ‡ |
USA** |
4 (19.0%) |
40 (61.5%) |
| Europe*** |
6 (10.5%) |
127 (75.6%) |
|
| Total*** |
10 (12.8%) |
167 (71.7%) |
|
|
Number of OAB-related physician visits over the past 3 months‡‡ |
USA |
1.3 (1.2) |
1.5 (1.3) |
| Europe |
2.2 (2.4) |
2.5 (2.3) |
|
| Total |
2.0 (2.1) |
2.2 (2.0) |
|
| Number of pads used per week‡‡ | USA |
4.5 (12.2) |
10.8 (14.4) |
| Europe*** |
0.8 (2.4) |
9.3 (9.0) |
|
| Total*** | 1.8 (6.7) | 9.7 (10.8) | |
aBivariate analyses comparing burden of illness between incontinent versus non-incontinent group.
b11 out of 324 NDO patients had unknown incontinent status.
*p < 0.05 **p < 0.01 ***p < 0.001 in chi-square test, Fisher’s exact test, t-test, or Wilcoxon rank-sum test as appropriate.
‡Data are presented as number (percentage).
‡‡Data are presented as mean (standard deviation).